rs193303018
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PS4_ModeratePM6_SupportingPS3_ModeratePM2_Supporting
This summary comes from the ClinGen Evidence Repository: The m.3242G>A variant in MT-TL1 has been reported in at least six unrelated individuals with primary mitochondrial disease (PMIDs: 15870203, 19460299, 10214753, 21364701, 14576046, 22781753, 24667782, 31965079, 37038312; PS4_moderate). Clinical features in affected individuals include Leigh syndrome spectrum disorder, encephalomyopathy, myopathy, hypertrophic and dilated cardiomyopathy, and renal insufficiency. The variant occurred de novo in two of these individuals (PMID:22781753; PM6_supporting). There are no families reported where the variant segregated with clinical manifestations. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). In silico predictors are conflicting as the computational predictor MitoTIP suggests this variant is likely benign (18.5 percentile) but HmtVAR predicts it to be possibly pathogenic with a score of 0.6. A cybrid study (PMID:19460299) from cells derived from the index case (PMID:15870203) demonstrated reduced activity of complex IV. Additional studies showed this variant eliminated transcriptional termination activity with a modest decrease (30%–50%) of mtRNase P activity (PMID:20550934), and that this variant was associated with decreased single-turnover methyltransferase and cleavage activity of human mitochondrial mtRNase P (PS3_moderate). In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on November 11, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID:32906214): PS4_moderate, PS3_moderate, PM2_supporting, PM6_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA280144/MONDO:0044970/015
Frequency
Consequence
unassigned_transcript_4788 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: Mitochondrial Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRNL1 | unassigned_transcript_4788 | c.13G>A | p.Glu5Lys | missense_variant | Exon 1 of 1 | |||
| ND1 | unassigned_transcript_4789 | c.-65G>A | upstream_gene_variant | |||||
| RNR2 | unassigned_transcript_4787 | n.*13G>A | downstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MT-TL1 | ENST00000386347.1 | n.13G>A | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| MT-ND1 | ENST00000361390.2 | c.-65G>A | upstream_gene_variant | 6 | ENSP00000354687.2 | |||||
| MT-RNR2 | ENST00000387347.2 | n.*13G>A | downstream_gene_variant | 6 |
Frequencies
Mitomap
ClinVar
Submissions by phenotype
MELAS syndrome Pathogenic:2
- -
The NC_012920.1:m.3242G>A variant in MT-TL1 gene is interpreted to be a Likely Pathogenic variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes reported in the guidelines: PS5, PM9, PM10 -
Myelodysplastic syndrome Pathogenic:1
- -
Mitochondrial disease Pathogenic:1
The m.3242G>A variant in MT-TL1 has been reported in at least six unrelated individuals with primary mitochondrial disease (PMIDs: 15870203, 19460299, 10214753, 21364701, 14576046, 22781753, 24667782, 31965079, 37038312; PS4_moderate). Clinical features in affected individuals include Leigh syndrome spectrum disorder, encephalomyopathy, myopathy, hypertrophic and dilated cardiomyopathy, and renal insufficiency. The variant occurred de novo in two of these individuals (PMID: 22781753; PM6_supporting). There are no families reported where the variant segregated with clinical manifestations. This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). In silico predictors are conflicting as the computational predictor MitoTIP suggests this variant is likely benign (18.5 percentile) but HmtVAR predicts it to be possibly pathogenic with a score of 0.6. A cybrid study (PMID: 19460299) from cells derived from the index case (PMID: 15870203) demonstrated reduced activity of complex IV. Additional studies showed this variant eliminated transcriptional termination activity with a modest decrease (30%–50%) of mtRNase P activity (PMID: 20550934), and that this variant was associated with decreased single-turnover methyltransferase and cleavage activity of human mitochondrial mtRNase P (PS3_moderate). In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on November 11, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS4_moderate, PS3_moderate, PM2_supporting, PM6_supporting. -
Computational scores
Source: